Extend your brand profile by curating daily news.

Los Angeles Clinic Achieves 85% Success Rate with Personalized Ketamine Therapy Approach

By FisherVista

TL;DR

NeuroRelief's personalized IV ketamine therapy offers a competitive edge with an 85% success rate for treating depression, anxiety, and chronic pain through Dr. Austin Harris's innovative approach.

Dr. Austin Harris combines IV ketamine with NAD+ infusions and micronutrient therapy in customized programs based on each patient's neurology, psychology, and physiology for targeted treatment.

NeuroRelief provides hope and healing to those failed by traditional treatments, making tomorrow better through accessible, compassionate care that transforms mental health and chronic pain recovery.

Dr. Austin Harris offers patients 24/7 access to his personal cell phone and integrates mindfulness with ketamine therapy for a unique healing journey.

Found this article helpful?

Share it with your network and spread the knowledge!

Los Angeles Clinic Achieves 85% Success Rate with Personalized Ketamine Therapy Approach

A medical practice in Los Angeles is reporting significant success in treating complex mental health and chronic pain conditions through a novel, highly personalized approach to IV ketamine therapy. NeuroRelief Ketamine & Infusion Therapy, founded and directed by Dr. Austin Harris, has developed a treatment model that has achieved an 85% success rate for conditions including depression, anxiety, PTSD, migraines, chronic pain syndromes, and substance abuse recovery.

The importance of this development lies in its potential to offer effective treatment for individuals who have not found relief through traditional psychiatric and pain management approaches. With mental health disorders and chronic pain affecting millions globally, innovative and effective treatments are critically needed. Dr. Harris, a board-certified cardiothoracic anesthesiologist with over 12 years of specialized ketamine experience, states the mission is to provide hope and healing to those who have struggled. "EVERY single person deserves the right to find relief," Dr. Harris said.

The clinic's impact stems from its departure from conventional models. The practice operates on a "one-size-fits-one" philosophy, creating fully customized programs for each patient. Treatment integrates IV ketamine therapy with NAD+ infusion therapy and micronutrient infusions, tailored to an individual's unique neurology, psychology, and physiology. This personalized methodology is a significant shift from more standardized treatment protocols and may represent a more effective pathway for complex, treatment-resistant conditions.

Further differentiating the practice is its model of "fully integrated" care. Each patient receives one-on-one support from professionals who provide training in sustainable healing practices like mindfulness meditation and mindful cognitive behavioral therapy. Certified integration and recovery coaching are also part of the program. In a notable commitment to patient support, Dr. Harris provides all patients with seven-day-a-week real-time access to his personal cell phone, serving as a continuous guide throughout treatment.

Dr. Harris's medical credentials underpin the clinic's approach. He earned his Doctor of Medicine degree, Magna Cum Laude, from St. George's University School of Medicine, completed residency at UC Irvine, and a fellowship at the Keck School of Medicine, USC. He is also certified in Psychedelic Integration Therapy and Psychedelic-Assisted Psychotherapy through Fluence. His extensive background in cardiac, thoracic, and pediatric anesthesiology at major Los Angeles hospitals informs a treatment philosophy that bridges rigorous medical science with integrative healing.

The implications of this work extend beyond the clinic's walls. As a frequent speaker at national conferences on psychedelic medicine and ketamine therapy, Dr. Harris advocates for the safe and compassionate use of ketamine in modern medicine. His work also encompasses a commitment to supporting veterans and underserved communities through pro bono care and public education on the ethical use of psychedelic therapies. This combination of high clinical success rates, personalized care, and advocacy positions the clinic's model as a potentially influential development in the evolving landscape of mental health and chronic pain treatment, highlighting a shift towards more holistic, accessible, and patient-centered therapeutic interventions.

Curated from 24-7 Press Release

blockchain registration record for this content
FisherVista

FisherVista

@fishervista